src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-8050569412065003" crossorigin="anonymous">[/script]
Headlines

Hims & Hers shares fall after FDA says semaglutide no longer in shortage newsthirst.

Shares of Hims & Hers Health tumbled more than 23% on Friday after the U.S. Food and Drug Administration announced that the shortage of semaglutide injection products has been resolved. Semaglutide is the active ingredient in Novo Nordisk’s blockbuster weight loss drug Wegovy and diabetes treatment Ozempic. Those medications are part of a class of drugs called…

Read More

Business can no longer ignore ‘north-south’ climate divide: UN newsthirst.

The United Nations’ top corporate sustainability chief warned business leaders they can no longer ignore the growing “north-south divide” on climate change. Sanda Ojiambo, CEO and executive director of U.N. Global Compact — a body responsible for overseeing business commitments to achieving sustainable development goals — told CNBC’s Steve Sedgewick that “climate has become a…

Read More